Topic · page 45 of 119

Type 2 & other diabetes

Type 2 diabetes and prediabetes: prevention, remission, glucose-lowering drugs, weight-based treatment, insulin, lifestyle and diet; monogenic and other specific types of diabetes

Briefs 1,761–1,800 of 4,758 placed here, newest publication first

Briefs in Type 2 & other diabetes

Newest publication first

Diabetes Res Clin Pract2 May 2025
Baseline glucagon impacts glucose-lowering effects of acarbose but not metformin: A sub-analysis of MARCH study
Secondary analysis
Diabetologia2 May 2025
Treatment discontinuation among users of GLP-1 receptor agonists and SGLT2 inhibitors in a national population of individuals with type 2 diabetes
Cohort study
Diabetologia2 May 2025
Duration and type of statin use and long-term risk of type 2 diabetes among men and women with hypercholesterolaemia: findings from three prospective cohorts
Cohort study
Diabetes Obes Metab2 May 2025
Mortality risk following ischaemic and non‐ischaemic heart failure in people with type 2 diabetes: Observational study in England, 2000–2021
Cohort study
Eur J Endocrinol2 May 2025
Genetic predisposition to adiposity, and type 2 diabetes: the role of lifestyle and phenotypic adiposity
Cohort study
JAMA Netw Open1 May 2025
Geographic and Sociodemographic Factors and Receipt of Metabolic Disease Specialty Care
Cohort study
JAMA Intern Med1 May 2025
Multivitamins After Myocardial Infarction in Patients With Diabetes: A Randomized Clinical Trial
Randomized controlled trial
JAMA Netw Open1 May 2025
Real-Time AI-Assisted Insulin Titration System for Glucose Control in Patients With Type 2 Diabetes: A Randomized Clinical Trial
Randomized controlled trial
Diabetes Obes Metab30 Apr 2025
Fotagliptin add‐on therapy to metformin in patients with uncontrolled type 2 diabetes: A randomised, multicentre, double‐blind, placebo‐controlled, phase 3 trial
Randomized controlled trial
J Clin Endocrinol Metab30 Apr 2025
Regional Brain Structure Alterations in Diabetes but Not Prediabetes
Cross-sectional study
Lancet Diabetes Endocrinol30 Apr 2025
Tirzepatide and muscle composition changes in people with type 2 diabetes (SURPASS-3 MRI): a post-hoc analysis of a randomised, open-label, parallel-group, phase 3 trial
Secondary analysis
Diabetes Res Clin Pract29 Apr 2025
The relationship of inflammatory markers NLR and PLR with HbA1c in Turkish diabetic patients
Cohort study
J Diabetes Sci Technol29 Apr 2025
Leveraging Co-Design, Design Thinking, and Service Blueprinting to Create Digital Health Behavior Change Innovations: Insights From a Co-Design Workshop With Type 2 Diabetes Remission Health Coaches
Research article
Diabetes Obes Metab28 Apr 2025
Association between the body mass index and risk of cardiovascular events in sodium‐glucose cotransporter 2 inhibitor users compared with dipeptidyl‐peptidase 4 inhibitor users: A nationwide cohort study in Korea
Cohort study
Lancet Diabetes Endocrinol28 Apr 2025
Long-term effects and effect heterogeneity of lifestyle and metformin interventions on type 2 diabetes incidence over 21 years in the US Diabetes Prevention Program randomised clinical trial
Randomized controlled trial
Endocr Pract28 Apr 2025
Glucagon-like Peptide-1 Receptor Agonists Are Associated With Improved Survival and Reduced Liver-Related Events in Patients With Type 2 Diabetes and Metabolic Dysfunction-Associated Liver Disease: A Large Real-World Retrospective Study
Cohort study
J Clin Endocrinol Metab28 Apr 2025
SHBG, Testosterone, and Type 2 Diabetes Risk in Middle-Aged African Women: Exploring the Effect of HIV and Menopause
Cross-sectional study
BMJ Open Diabetes Res Care27 Apr 2025
Glycemic and non-glycemic benefits of initial triple therapy versus sequential add-on therapy in patients with new-onset diabetes: results from the EDICT study
Secondary analysis
Diabet Med27 Apr 2025
Glycated albumin and fructosamine do not improve accuracy of glycaemic control assessment in patients with conditions reported to affect HbA 1c reliability
Diagnostic or prognostic study
Pediatr Diabetes27 Apr 2025
Pediatric Hepatocyte Nuclear Factor 1B ( HNF1B ) Disease: Diabetes and Endocrine Manifestations
Cohort study
Diabetes Res Clin Pract26 Apr 2025
Cardiovascular and renal outcomes between sodium-glucose cotransporter 2 inhibitors and dipeptidyl peptidase 4 inhibitors in patients with chronic kidney disease stages 4 and 5: a population-based study
Cohort study
Diabetes Res Clin Pract26 Apr 2025
Pharmacological interventions for smoking cessation in Type 2 diabetes: A systematic review with meta-analysis and GRADE evaluation
Meta-analysis
Diabetes Res Clin Pract26 Apr 2025
Brief report: Validity of self-report measures of medication adherence in young adults with youth-onset type 2 diabetes
Diagnostic or prognostic study
Cardiovasc Diabetol26 Apr 2025
Cardiorenal protection with dapagliflozin in patients with type 2 diabetes mellitus and chronic coronary syndrome undergoing percutaneous coronary intervention: a registry cross-sectional study
Cross-sectional study
Endocr Pract25 Apr 2025
Trends and Risk Factors of Oral Health and Preventive Dental Care in Adults With Diabetes and Prediabetes: National Health and Nutrition Examination Survey 1999-2000 to 2017-2020
Cross-sectional study
Cardiovasc Diabetol25 Apr 2025
The effect of empagliflozin on peripheral microvascular dysfunction in patients with heart failure with preserved ejection fraction
Research article
Diabet Med25 Apr 2025
The cardio‐renal‐metabolic role of the nod‐like receptor protein‐3 and senescence‐associated secretory phenotype in early sodium/glucose cotransporter‐2 inhibitor therapy in people with diabetes who have had a myocardial infarction
Randomized controlled trial
Diabetes Care25 Apr 2025
High-Dose Semaglutide (Up to 16 mg) in People With Type 2 Diabetes and Overweight or Obesity: A Randomized, Placebo-Controlled, Phase 2 Trial
Randomized controlled trial
Cardiovasc Diabetol24 Apr 2025
Association of stress hyperglycemia ratio with short-term and long-term prognosis in patients undergoing coronary artery bypass grafting across different glucose metabolism states: a large-scale cohort study
Cohort study
Cardiovasc Diabetol24 Apr 2025
Real-world effectiveness of adding newer generation GLP-1RA to SGLT2i in type 2 diabetes
Cohort study
Diabetes Care24 Apr 2025
Comparison of Insulin Titration Strategies for Glycemic Control in Type 2 Diabetes: A Systematic Review and Network Meta-analysis
Meta-analysis
BMJ Open Diabetes Res Care23 Apr 2025
GLP-1 RA and dual GIP/GLP-1 RA treatment in MODY: a descriptive case series
Cohort study
Diabetes Obes Metab23 Apr 2025
Long‐term adherence to glucose‐lowering medications in adults with diabetes: A data linkage study
Cohort study
J Clin Endocrinol Metab23 Apr 2025
Development and Validation of a Diabetes Risk Prediction Model With Individualized Preventive Intervention Effects
Diagnostic or prognostic study
Diabetes Care23 Apr 2025
Lipidomic Markers of Processed Meat and Unprocessed Red Meat Intake and Risk of Diabetes in American Indians
Cohort study
Diabetes Care23 Apr 2025
Weight Gain Was Associated With Worsening Glycemia and Cardiovascular and Kidney Outcomes in Patients With Type 2 Diabetes Independent of Diabetes Medication in the GRADE Randomized Controlled Trial
Secondary analysis
Diabetes Res Clin Pract22 Apr 2025
Plasma proteomic signatures for type 2 diabetes and related traits in the UK Biobank cohort
Cohort study
Ann Intern Med22 Apr 2025
Availability of Cardioprotective Medications for Type 2 Diabetes in the Medicaid Program
Cross-sectional study
Diabetes Res Clin Pract21 Apr 2025
Associations between disease acceptance and dietary adherence in patients with type 2 diabetes mellitus in China: a cross-sectional study
Cross-sectional study
Diabetes Res Clin Pract21 Apr 2025
Risk of dementia after initiation of sodium-glucose cotransporter-2 inhibitors versus dipeptidyl peptidase-4 inhibitors in older adults with type 2 diabetes: A five-year retrospective cohort analysis of 160,752 patients
Cohort study

All 4,758 Briefs in ExploreShowing Briefs 1,761–1,800 of 4,758, newest first